Cell-penetrating peptides: classes, origin, and current landscape.

[1]  Asher Mullard,et al.  Protein–protein interaction inhibitors get into the groove , 2012, Nature Reviews Drug Discovery.

[2]  Wei Guo,et al.  A cell-penetrating peptide suppresses inflammation by inhibiting NF-κB signaling. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[3]  J. Ochocki,et al.  Evaluation of a cell penetrating prenylated peptide lacking an intrinsic fluorophore via in situ click reaction. , 2011, Bioorganic & medicinal chemistry letters.

[4]  Susan M. Bridges,et al.  Prediction of Cell Penetrating Peptides by Support Vector Machines , 2011, PLoS Comput. Biol..

[5]  Kairong Wang,et al.  Design of acid-activated cell penetrating peptide for delivery of active molecules into cancer cells. , 2011, Bioconjugate chemistry.

[6]  Jesse K. Placone,et al.  Spontaneous membrane-translocating peptides by orthogonal high-throughput screening. , 2011, Journal of the American Chemical Society.

[7]  Scott Banta,et al.  An unusual cell penetrating peptide identified using a plasmid display-based functional selection platform. , 2011, ACS chemical biology.

[8]  M. Akashi,et al.  Fibroblast Growth Factor-12 (FGF12) Translocation into Intestinal Epithelial Cells Is Dependent on a Novel Cell-penetrating Peptide Domain , 2011, The Journal of Biological Chemistry.

[9]  Irene Martín,et al.  Design, Synthesis and Characterization of a New Anionic Cell‐Penetrating Peptide: SAP(E) , 2011, Chembiochem : a European journal of chemical biology.

[10]  Astrid Gräslund,et al.  Mechanisms of Cellular Uptake of Cell-Penetrating Peptides , 2011, Journal of biophysics.

[11]  I. Neundorf,et al.  Antimicrobial peptides with cell-penetrating peptide properties and vice versa , 2011, European Biophysics Journal.

[12]  B. Nordén,et al.  Dual functions of the human antimicrobial peptide LL-37-target membrane perturbation and host cell cargo delivery. , 2010, Biochimica et biophysica acta.

[13]  D. Hájková,et al.  Cell-Penetrating Penta-Peptides (CPP5s): Measurement of Cell Entry and Protein-Transduction Activity , 2010, Pharmaceuticals.

[14]  I. Mäger,et al.  In vivo biodistribution and efficacy of peptide mediated delivery. , 2010, Trends in pharmacological sciences.

[15]  Alphonse García,et al.  PP2A1 Binding, Cell Transducing and Apoptotic Properties of Vpr77–92: A New Functional Domain of HIV-1 Vpr Proteins , 2010, PloS one.

[16]  E. Gulbins,et al.  Cationic cell-penetrating peptides induce ceramide formation via acid sphingomyelinase: implications for uptake. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[17]  A. Shevchenko,et al.  Lipidomics: coming to grips with lipid diversity , 2010, Nature Reviews Molecular Cell Biology.

[18]  Ű. Langel,et al.  Secondary structure of cell-penetrating peptides controls membrane interaction and insertion. , 2010, Biochimica et biophysica acta.

[19]  M. Mano,et al.  S4(13)-PV cell-penetrating peptide forms nanoparticle-like structures to gain entry into cells. , 2010, Bioconjugate chemistry.

[20]  O. Mendoza,et al.  Identification of a novel antitumor peptide based on the screening of an Ala‐library derived from the LALF32–51 region , 2010, Journal of peptide science : an official publication of the European Peptide Society.

[21]  A. Fukamizu,et al.  Isolation of novel cell-penetrating peptides from a random peptide library using in vitro virus and their modifications. , 2009, International journal of molecular medicine.

[22]  Charalampos G. Kalodimos,et al.  Signal peptides are allosteric activators of the protein translocase , 2009, Nature.

[23]  S. Futaki,et al.  Cell-surface accumulation of flock house virus-derived peptide leads to efficient internalization via macropinocytosis. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[24]  J. J. Nestor,et al.  The medicinal chemistry of peptides. , 2009, Current medicinal chemistry.

[25]  G. W. Vuister,et al.  A Cell-penetrating Peptide Derived from Human Lactoferrin with Conformation-dependent Uptake Efficiency , 2009, The Journal of Biological Chemistry.

[26]  Isabel D. Alves,et al.  Translocation and Endocytosis for Cell-penetrating Peptide Internalization , 2009, The Journal of Biological Chemistry.

[27]  L. Traub.  Tickets to ride: selecting cargo for clathrin-regulated internalization , 2009, Nature Reviews Molecular Cell Biology.

[28]  A. Eguchi,et al.  siRNA delivery using peptide transduction domains. , 2009, Trends in pharmacological sciences.

[29]  M. Morris,et al.  Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics , 2009, British journal of pharmacology.

[30]  C. Beattie,et al.  Noncationic peptides obtained from azurin preferentially enter cancer cells. , 2009, Cancer research.

[31]  J. Chmielewski,et al.  Cationic Amphiphilic Polyproline Helices: Side‐Chain Variations and Cell‐Specific Internalization , 2009, Chemical Biology and Drug Design.

[32]  R. Brasseur,et al.  A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[33]  S. Sugawara,et al.  Cell‐penetrating peptide‐conjugated XIAP‐inhibitory cyclic hexapeptides enter into Jurkat cells and inhibit cell proliferation , 2008, The FEBS journal.

[34]  P. Boisguérin,et al.  Comparison of cellular uptake using 22 CPPs in 4 different cell lines. , 2008, Bioconjugate chemistry.

[35]  P. Lundin,et al.  Distinct uptake routes of cell-penetrating peptide conjugates. , 2008, Bioconjugate chemistry.

[36]  John Calvin Reed,et al.  A short Nur77-derived peptide converts Bcl-2 from a protector to a killer. , 2008, Cancer cell.

[37]  Chunxiao Wu,et al.  A peptide-based carrier for intracellular delivery of proteins into malignant glial cells in vitro. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[38]  A. Debnath,et al.  A cell-penetrating helical peptide as a potential HIV-1 inhibitor. , 2008, Journal of molecular biology.

[39]  W. Arap,et al.  Combinatorial Targeting of the Macropinocytotic Pathway in Leukemia and Lymphoma Cells* , 2008, Journal of Biological Chemistry.

[40]  A. Herrmann,et al.  Live‐cell analysis of cell penetration ability and toxicity of oligo‐arginines , 2008, Journal of peptide science : an official publication of the European Peptide Society.

[41]  J. Seelig,et al.  Binding and clustering of glycosaminoglycans: a common property of mono- and multivalent cell-penetrating compounds. , 2008, Biophysical journal.

[42]  Ű. Langel,et al.  Predicting cell-penetrating peptides. , 2008, Advanced drug delivery reviews.

[43]  A. Schepartz,et al.  Minimally cationic cell-permeable miniature proteins via alpha-helical arginine display. , 2008, Journal of the American Chemical Society.

[44]  S. Futaki,et al.  Cellular internalization and distribution of arginine-rich peptides as a function of extracellular peptide concentration, serum, and plasma membrane associated proteoglycans. , 2008, Bioconjugate chemistry.

[45]  G. Meer,et al.  Membrane lipids: where they are and how they behave , 2008, Nature Reviews Molecular Cell Biology.

[46]  Ű. Langel,et al.  Relevance of the N-terminal NLS-like sequence of the prion protein for membrane perturbation effects. , 2008, Biochimica et biophysica acta.

[47]  Henrik J Johansson,et al.  Characterization of a Novel Cytotoxic Cell-penetrating Peptide Derived From p14ARF Protein. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[48]  A. Schepartz,et al.  Intrinsically cell-permeable miniature proteins based on a minimal cationic PPII motif. , 2007, Journal of the American Chemical Society.

[49]  Ü. Langel,et al.  A Novel Cell-penetrating Peptide, M918, for Efficient Delivery of Proteins and Peptide Nucleic Acids. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[50]  Ü. Langel,et al.  Delivery of short interfering RNA using endosomolytic cell‐penetrating peptides , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[51]  Satyajit Mayor,et al.  Pathways of clathrin-independent endocytosis , 2007, Nature Reviews Molecular Cell Biology.

[52]  Ignacio Aguaded,et al.  Bax-inhibiting peptides derived from Ku70 and cell-penetrating pentapeptides. , 2007, Biochemical Society Transactions.

[53]  Rainer Fischer,et al.  A Comprehensive Model for the Cellular Uptake of Cationic Cell‐penetrating Peptides , 2007, Traffic.

[54]  J. Seelig,et al.  High affinity of the cell-penetrating peptide HIV-1 Tat-PTD for DNA. , 2007, Biochemistry.

[55]  S. Korsmeyer,et al.  Reactivation of the p53 tumor suppressor pathway by a stapled p53 peptide. , 2007, Journal of the American Chemical Society.

[56]  S. Korsmeyer,et al.  Reactivation of the p53 Tumor Suppressor Pathway by a Stapled p53 Peptide , 2007 .

[57]  Y. Tsutsumi,et al.  Creation of novel cell-penetrating peptides for intracellular drug delivery using systematic phage display technology originated from Tat transduction domain. , 2007, Biological & pharmaceutical bulletin.

[58]  S. Sagan,et al.  Tracking a new cell-penetrating (W/R) nonapeptide, through an enzyme-stable mass spectrometry reporter tag. , 2007, Analytical chemistry.

[59]  Richard G. W. Anderson,et al.  Lipid rafts: at a crossroad between cell biology and physics , 2007, Nature Cell Biology.

[60]  Ű. Langel,et al.  Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery. , 2006, Current opinion in pharmacology.

[61]  Ű. Langel,et al.  N-terminal peptides from unprocessed prion proteins enter cells by macropinocytosis. , 2006, Biochemical and biophysical research communications.

[62]  D. Heistad,et al.  Endocytosis of Extracellular Superoxide Dismutase Into Endothelial Cells: Role of the Heparin-Binding Domain , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[63]  Christoph Patsch,et al.  The FASEB Journal Research Communication Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells , 2022 .

[64]  Sangwei Lu,et al.  A cell-penetrating peptide derived from mammalian cell uptake protein of Mycobacterium tuberculosis. , 2006, Analytical biochemistry.

[65]  M. Prieto,et al.  Cellular uptake of S413-PV peptide occurs upon conformational changes induced by peptide-membrane interactions. , 2006, Biochimica et biophysica acta.

[66]  Ű. Langel,et al.  Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide. , 2006, Biochemical pharmacology.

[67]  P. Watt,et al.  Screening for peptide drugs from the natural repertoire of biodiverse protein folds , 2006, Nature Biotechnology.

[68]  M. Rhee,et al.  Mechanism of Uptake of C105Y, a Novel Cell-penetrating Peptide* , 2006, Journal of Biological Chemistry.

[69]  O. Lequin,et al.  Comparison of penetratin and other homeodomain-derived cell-penetrating peptides: interaction in a membrane-mimicking environment and cellular uptake efficiency. , 2006, Biochemistry.

[70]  Harvey T. McMahon,et al.  Membrane curvature and mechanisms of dynamic cell membrane remodelling , 2005, Nature.

[71]  Ralph Weissleder,et al.  Protamine as an efficient membrane-translocating peptide. , 2005, Bioconjugate chemistry.

[72]  M. Giacca,et al.  Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules. , 2005, The Biochemical journal.

[73]  J. Chmielewski,et al.  Cell penetrating agents based on a polyproline helix scaffold. , 2005, Journal of the American Chemical Society.

[74]  S. Bonner-Weir,et al.  Mechanism of PDX-1 protein transduction. , 2005, Biochemical and biophysical research communications.

[75]  R. Meloen,et al.  Application, efficiency and cargo-dependence of transport peptides , 2005 .

[76]  S. Korsmeyer,et al.  Activation of Apoptosis in Vivo by a Hydrocarbon-Stapled BH3 Helix , 2004, Science.

[77]  M. Sawada,et al.  Bax-inhibiting peptide derived from mouse and rat Ku70. , 2004, Biochemical and biophysical research communications.

[78]  I. Kerkis,et al.  Crotamine is a novel cell‐penetrating protein from the venom of rattlesnake Crotalus durissus terrificus , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[79]  H. M. Nielsen,et al.  Cellular Uptake But Low Permeation of Human Calcitonin-Derived Cell Penetrating Peptides and Tat(47-57) Through Well-Differentiated Epithelial Models , 2004, Pharmaceutical Research.

[80]  F. Szoka,et al.  GALA: a designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery. , 2004, Advanced drug delivery reviews.

[81]  L. Otvos,et al.  An insect antibacterial peptide-based drug delivery system. , 2004, Molecular pharmaceutics.

[82]  B. Nordén,et al.  Membrane binding and translocation of cell-penetrating peptides. , 2004, Biochemistry.

[83]  J. Dorsey,et al.  Evaluation of methods for measuring amino acid hydrophobicities and interactions. , 2003, Journal of chromatography. A.

[84]  R. Lerner,et al.  A cell-penetrating peptide from a novel pVII-pIX phage-displayed random peptide library. , 2002, Bioorganic & medicinal chemistry.

[85]  Ű. Langel,et al.  Cell membrane translocation of the N-terminal (1-28) part of the prion protein. , 2002, Biochemical and biophysical research communications.

[86]  J. Tam,et al.  Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7. , 2002, Biochemistry.

[87]  A. Hopkins,et al.  The druggable genome , 2002, Nature Reviews Drug Discovery.

[88]  J. Chmielewski,et al.  Cellular import mediated by nuclear localization signal Peptide sequences. , 2002, Chemistry & biology.

[89]  J. Langedijk.  Translocation Activity of C-terminal Domain of Pestivirus Erns and Ribotoxin L3 Loop* , 2002, The Journal of Biological Chemistry.

[90]  A. Kuliopulos,et al.  Activation and inhibition of G protein-coupled receptors by cell-penetrating membrane-tethered peptides , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[91]  G. Weiss,et al.  CHAPTER 13 – DNA-ENCODED PEPTIDE LIBRARIES AND DRUG DISCOVERY , 2002 .

[92]  M. Morris,et al.  A peptide carrier for the delivery of biologically active proteins into mammalian cells , 2001, Nature Biotechnology.

[93]  Ű. Langel,et al.  Cellular internalization of a cargo complex with a novel peptide derived from the third helix of the islet-1 homeodomain. Comparison with the penetratin peptide. , 2001, Bioconjugate chemistry.

[94]  T. Bártfai,et al.  VE-cadherin-derived cell-penetrating peptide, pVEC, with carrier functions. , 2001, Experimental cell research.

[95]  S. Futaki,et al.  Arginine-rich Peptides , 2001, The Journal of Biological Chemistry.

[96]  C. Rousselle,et al.  Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: saturation kinetics and specificity. , 2001, The Journal of pharmacology and experimental therapeutics.

[97]  Soo‐Young Choi,et al.  Efficient Intracellular Delivery of GFP by Homeodomains of Drosophila Fushi-tarazu and Engrailed Proteins , 2000, Molecules and cells.

[98]  G. Clayman,et al.  Isolation of a peptide for targeted drug delivery into human head and neck solid tumors. , 2000, Cancer research.

[99]  Kai Simons,et al.  Lipid rafts and signal transduction , 2000, Nature Reviews Molecular Cell Biology.

[100]  S. Ghosh,et al.  Selective inhibition of NF-κB activation by a peptide that blocks the interaction of NEMO with the IκB kinase complex , 2000 .

[101]  R. Brasseur,et al.  Deletion analogues of transportan. , 2000, Biochimica et biophysica acta.

[102]  C. B. Park,et al.  Interactions of the novel antimicrobial peptide buforin 2 with lipid bilayers: proline as a translocation promoting factor. , 2000, Biochemistry.

[103]  G. Verdine,et al.  An All-Hydrocarbon Cross-Linking System for Enhancing the Helicity and Metabolic Stability of Peptides , 2000 .

[104]  E. Hildt,et al.  Novel cell permeable motif derived from the PreS2-domain of hepatitis-B virus surface antigens , 2000, Gene Therapy.

[105]  C. Rousselle,et al.  New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy. , 2000, Molecular pharmacology.

[106]  J. Pober,et al.  Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. , 2000, Science.

[107]  B. Wiesner,et al.  Structural requirements for cellular uptake of α‐helical amphipathic peptides , 1999 .

[108]  M. Heinzelmann,et al.  Endocytosis of heparin-binding protein (CAP37) is essential for the enhancement of lipopolysaccharide-induced TNF-alpha production in human monocytes. , 1999, Journal of immunology.

[109]  B. Wiesner,et al.  Rapid translocation of amphipathic βhelical and β-sheet-forming peptides through plasma membranes of endothelial cells , 1999 .

[110]  B. Wiesner,et al.  Cellular uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically. , 1998, Biochimica et biophysica acta.

[111]  S. Wold,et al.  New chemical descriptors relevant for the design of biologically active peptides. A multivariate characterization of 87 amino acids. , 1998, Journal of medicinal chemistry.

[112]  M. Pooga,et al.  Cell penetration by transportan. , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[113]  B. Wiesner,et al.  Extensive cellular uptake into endothelial cells of an amphipathic β‐sheet forming peptide , 1997, FEBS letters.

[114]  L. Chaloin,et al.  Conformations of primary amphipathic carrier peptides in membrane mimicking environments. , 1997, Biochemistry.

[115]  L. Chaloin,et al.  A new peptide vector for efficient delivery of oligonucleotides into mammalian cells. , 1997, Nucleic acids research.

[116]  G. Elliott,et al.  Intercellular Trafficking and Protein Delivery by a Herpesvirus Structural Protein , 1997, Cell.

[117]  A. Prochiantz.  Getting hydrophilic compounds into cells: lessons from homeopeptides , 1996, Current Opinion in Neurobiology.

[118]  A. Prochiantz,et al.  Cell Internalization of the Third Helix of the Antennapedia Homeodomain Is Receptor-independent* , 1996, The Journal of Biological Chemistry.

[119]  T. Torgerson,et al.  Inhibition of Nuclear Translocation of Transcription Factor NF-κB by a Synthetic Peptide Containing a Cell Membrane-permeable Motif and Nuclear Localization Sequence (*) , 1995, The Journal of Biological Chemistry.

[120]  D. Ludevid,et al.  Two Structural Domains Mediate Two Sequential Events in [gamma]-Zein Targeting: Protein Endoplasmic Reticulum Retention and Protein Body Formation. , 1994, The Plant cell.

[121]  W. Gehring,et al.  Homeodomain proteins. , 1994, Annual review of biochemistry.

[122]  M. Ishino,et al.  Mutational analysis of HIV-1 Tat minimal domain peptides: Identification of trans-dominant mutants that suppress HIV-LTR-driven gene expression , 1989, Cell.

[123]  G. Rose,et al.  Hydrophobicity of amino acid residues in globular proteins. , 1985, Science.

[124]  R. Steinman,et al.  Endocytosis and the recycling of plasma membrane , 1983, The Journal of cell biology.

[125]  M. Charton,et al.  The structural dependence of amino acid hydrophobicity parameters. , 1982, Journal of theoretical biology.

[126]  David Eisenberg,et al.  The helical hydrophobic moment: a measure of the amphiphilicity of a helix , 1982, Nature.

[127]  R. Doolittle,et al.  A simple method for displaying the hydropathic character of a protein. , 1982, Journal of molecular biology.